Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal ethinyl estradiol + norelgestromin for irregular bleeding in contraceptive implant users
TCTR20250118005Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Jul 2025
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of ethinyl estradiol + norelgestromin in menstrual disorders, sponsored by Faculty of Medicine, Chulalongkorn University. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
ethinyl estradiol + norelgestromin
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on TCTR20250118005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250118005.